Janux Therapeutics, Inc. ($JANX)
Filing Information
| Accession Number | 0002005618-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 3, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
143,805
Total Value
$34,393.65
P&L
+inf% (+$1,985,010.66)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 2, 2026 | Sale | 2,505 | $13.73 | $34,393.65 | 124,425 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 2, 2026 | Grant/Award | 31,400 | $0.00 | $0.00 | 155,825 | Direct | โ | View Details | |
Chief Scientific Officer | Stock option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 109,900 | $0.00 | $0.00 | 109,900 | Direct | โ | View Details |